Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Indica Labs Announces Collaboration with The Industrial Centre for Artificial Intelligence Research in Digital Diagnostics (iCAIRD) for the Development of an AI-based Algorithm for the Automated Reporting of Lymph Node Status in Colon Cancer
Indica Labs, an industry leader in quantitative digital pathology and image management solutions, and The […]
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio (formerly Luina Bio), a leading Australian biopharmaceutical CDMO, has been acquired by biotech investor […]
Digital Rehabilitation Platform Neurofenix Completes $7 Million Series A to Transform Stroke and Brain Injury Recovery
Neurofenix, the neurological rehabilitation platform that uses sensors to improve patient outcomes, has raised $7 million in […]
DiamiR Biosciences Expands Management Team with the Appointment of Fred Knechtel as its Chief Financial Officer
DiamiR, a developer of innovative blood-based diagnostic tests for brain health and other diseases, today […]
IVX Health Announces Opening of New Infusion Centers in Connecticut
IVX Health, a national provider of infusion and injection therapy for adult and pediatric patients with multiple […]
Castle Creek Biosciences Announces Publication of Preclinical Study for Potential In Vivo Gene Therapy in Nature Communications
Castle Creek Biosciences announced publication of a preclinical study that found that its experimental in vivo gene […]
Pfizer and BioNTech Complete Submission to European Medicines Agency for Omicron BA.4/BA.5 Adapted Bivalent
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the […]
Swissmedic Authorizes Moderna’s Omicron-targeting Bivalent Booster Candidate, mRNA-1273.214
Moderna, Inc. (NASDAQ:MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced […]
Single Pill Proves More Effective at Preventing Further Heart Attack or Stroke
A single pill containing medication to lower cholesterol and blood pressure and stop clotting is […]
Novo Holdings Leads $50 Million Investment in MedGenome to Accelerate Expansion Into New Markets and Deepen Product Offerings
MedGenome, the leading genetic diagnostics, research, and data company in South Asia, announced today a […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more